Zostavax is a live vaccine developed by Merck & Co. that has been shown to reduce the incidence of herpes zoster by 51.3% in a study of 38,000 adults aged 60 and older who received the vaccine. read more
Important pages are Shingles, Share and Resources. In the following table you'll find the 6 most important pages of Zostavax.ca:
# | Description | URL of the website |
---|---|---|
1. | Shingles | /symptoms_of_shingles.html |
2. | Share | http://www.zostavax.ca |
3. | Resources | /resources_on_shingles_vaccine.html |
4. | Zostavax | /vaccine_prevention_of_shingles.html |
5. | download brochure PDF | /Eng_Patient_Brochure.pdf |
6. | Consumer Information | http://www.zostavax.ca#dialog-confirm |
The websites of Zostavax.ca are served by a Nginx server. The HTML pages were created with the latest standard HTML 5. The website does not specify details about the inclusion of its content in search engines. For this reason the content will be included by search engines.
IP address: | 69.90.78.209 |
Server provider: | Peer 1 Network (USA) |
Webserver software: | Nginx |
Software platform: | PleskLin |
Load time: | 0.45 seconds (faster than 70 % of all websites) |
HTML version: | HTML 5 |
Filesize: | 14.48 KB (610 recognized words in text) |
The website doesn't contain questionable content. It can be used by kids and is safe for work.
Attribute | Classification | |
---|---|---|
Google Safebrowsing |
Safe | |
Safe for children |
||
Safe for work |
||
Webwiki rating |
No ratings | |
Server location |
USA, New York | |
Trustworthy 85% |